Compare SID & CTKB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SID | CTKB |
|---|---|---|
| Founded | 1941 | 1990 |
| Country | Brazil | United States |
| Employees | N/A | N/A |
| Industry | Steel/Iron Ore | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 833.8M | 777.3M |
| IPO Year | 2002 | 2021 |
| Metric | SID | CTKB |
|---|---|---|
| Price | $0.51 | $6.08 |
| Analyst Decision | Sell | Buy |
| Analyst Count | 4 | 3 |
| Target Price | $1.17 | ★ $6.50 |
| AVG Volume (30 Days) | ★ 10.8M | 1.2M |
| Earning Date | 11-12-2026 | 11-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $193,015,000.00 |
| Revenue This Year | N/A | $3.83 |
| Revenue Next Year | $1.87 | $6.48 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 17.67 |
| 52 Week Low | $0.55 | $3.31 |
| 52 Week High | $2.20 | $6.34 |
| Indicator | SID | CTKB |
|---|---|---|
| Relative Strength Index (RSI) | 24.87 | 56.45 |
| Support Level | N/A | $4.11 |
| Resistance Level | $1.34 | $6.27 |
| Average True Range (ATR) | 0.07 | 0.35 |
| MACD | -0.02 | 0.02 |
| Stochastic Oscillator | 1.23 | 72.22 |
Companhia Siderurgica Nacional is an integrated steel producer. together with its subsidiaries operates in five main business segments: Steel industry: production and marketing of flat and long steels; Mining: extraction, processing and marketing of iron ore, tin, limestone and dolomite; Cement: production and commercialization of bagged and bulk cement, in addition to aggregates, concrete, and other related products; Energy: generation and sale of energy from almost all renewable sources; and Logistics: participations port concessions and fleets of road transport vehicles. The group generates the majority of its revenue from the Steel industry segment. Geographically, it derives a majority of revenue from Asia.
Cytek Biosciences Inc is a cell analysis solutions company advancing the next generation of research and clinical tools with its novel technical approach of leveraging the full spectrum of fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells. Its patented FSP technology optimizes sensitivity and accuracy through its optical and electronic designs that utilize an inventive method of light detection and distribution to a specifically selected number and type of detectors. Its FSP cell analyzers, the Cytek Aurora, Northern Lights, and Cytek Aurora Evo systems, deliver high-resolution, high-content and high-sensitivity cell analysis and address the inherent limitations of other technologies.